/content/mofsl-website-adobe/fragments/open-demat-popup
style
hide-in-desktop

Veru Inc Share Price Today: Live Updates & Key Insights

Veru Inc share price today is $2.48, up -2.77%. The stock opened at $2.5 against the previous close of $2.53, with an intraday high of $2.515 and low of $2.45.

Veru Inc Share Price Chart

style
pb-0

Veru Inc

us-stock
To Invest in {{usstockname}}
/content/mofsl-website-adobe/demat-form-fields
style
sticky-block,pt-0
us-stock
style
pt-0

Veru Inc Share Price Performance

$2.48 -0.0277(-2.77%) VERU at 13 Mar 2026 03:44 PM Biotechnology
Lowest Today 2.45
Highest Today 2.515
Today’s Open 2.5
Prev. Close 2.53
52 Week High 7.40
52 Week Low 2.10
Day’s Range: Low 2.45 High 2.515
52-Week Range: Low 2.10 High 7.40
1 day return -
1 Week return -0.4
1 month return +8.37
3 month return +2.07
6 month return -30.11
1 year return +445.09
3 year return +21.78
5 year return -84.21
10 year return -

Veru Inc Institutional Holdings

Alyeska Investment Group, L.P. 6.23

Vanguard Group Inc 3.95

Vanguard Total Stock Mkt Idx Inv 2.37

Millennium Management LLC 1.44

Oppenheimer & Co Inc 1.23

GSA Capital Partners LLP 1.22

Summit Financial, LLC 1.02

Sheets Smith Investment Management 1.00

Geode Capital Management, LLC 0.99

Vanguard Institutional Extnd Mkt Idx Tr 0.99

Ikarian Capital, LLC 0.89

BlackRock Inc 0.71

UBS Group AG 0.63

Fidelity Extended Market Index 0.49

QRG Capital Management, Inc. 0.48

RSM US WEALTH MANAGEMENT LLC 0.47

Susquehanna International Group, LLP 0.42

State Street Corp 0.34

Citadel Advisors Llc 0.27

Blair William & Co 0.24

ADAR1 Capital Management LLC 0.22

BOOTHBAY FUND MANAGEMENT, LLC 0.20

Blackrock Extended Mkt Fund CF 0.16

Northern Trust Corp 0.16

Fidelity Total Market Index 0.14

Extended Equity Market Fund K 0.14

NT Ext Equity Mkt Idx Fd - L 0.13

T. Rowe Price U.S. Equities Tr 0.12

Fidelity Series Total Market Index 0.12

Spartan Extended Market Index Pool F 0.10

Goldman Sachs Absolute Ret Trckr Instl 0.09

Northern Trust Extended Eq Market Idx 0.08

NT Ext Equity Mkt Idx Fd - NL 0.07

Spartan Total Market Index Pool G 0.07

NT Ext Equity Mkt Idx Fd - DC - NL - T2 0.06

Fidelity Nasdaq Composite Index 0.05

NT Ext Eq Mkt Indx Fd DC Lending Tier 5 0.05

Vanguard Instl Ttl Stck Mkt Idx Tr 0.05

RBC O'Shaughnessy U.S. Growth Fund A 0.03

RBC O'Shaughnessy U.S. Growth Fund II F 0.01

Veru Inc Market Status

Strong Buy: 2

Buy: 2

Hold: 1

Sell: 0

Strong Sell: 0

Veru Inc Fundamentals

Market Cap 40.61 M

PB Ratio 1.0938

PE Ratio 0.0

Enterprise Value 8.19 M

Total Assets 29.84 M

Volume 79092

Veru Inc Company Financials

Annual Revenue FY25:0 0.0M, FY24:16886419 16.9M, FY23:16296958 16.3M, FY22:39354352 39.4M, FY21:61259528 61.3M

Annual Profit FY25:-152105 -0.2M, FY24:5853977 5.9M, FY23:7565928 7.6M, FY22:30591388 30.6M, FY21:47927223 47.9M

Annual Net worth FY25:-22726279 -22.7M, FY24:-37801426 -37.8M, FY23:-93088953 -93.1M, FY22:-83776020 -83.8M, FY21:7394374 7.4M

Quarterly Revenue Q4/2025:0 0.0M, Q3/2025:247064 0.2M, Q2/2025:0 0.0M, Q1/2025:0 0.0M, Q4/2024:0 0.0M

Quarterly Profit Q4/2025:-28193 -0.0M, Q3/2025:-28573 -0.0M, Q2/2025:-29331 -0.0M, Q1/2025:-29331 -0.0M, Q4/2024:null 0.0M

Quarterly Net worth Q4/2025:-5332579 -5.3M, Q3/2025:1453507 1.5M, Q2/2025:-7332820 -7.3M, Q1/2025:-7901619 -7.9M, Q4/2024:-8945347 -8.9M

About Veru Inc & investment objective

Company Information Veru Inc., a late clinical stage biopharmaceutical company, focuses on developing medicines for treatment of metabolic diseases, oncology, and viral-induced acute respiratory distress syndrome (ARDS) in Florida and internationally. It provides FC2 female condom for the dual protection against unplanned pregnancy and the transmission of sexually transmitted infections. The company develops enobosarm, a selective androgen receptor modulator for treatment of augment fat loss and to prevent muscle loss in sarcopenic obese and overweight elderly patients; Enobosarm, an oral selective androgen receptor modulator for the treatment of AR+ ER+ HER2- metastatic breast cancer; and sabizabulin, a microtubule disruptor for the treatment of hospitalized patients with viral lung infection at high risk for viral induced ARDS and death. The company was formerly known as The Female Health Company and changed its name to Veru Inc. in July 2017. Veru Inc. was incorporated in 1971 and is headquartered in Miami, Florida.

Organisation Biotechnology

Employees 20

Industry Biotechnology

CEO Dr. Mitchell S. Steiner F.A.C.S., M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right
style
align-center,button-arrow